Michael McCallister - Zoetis Non-Executive Independent Chairman of the Board

ZTS -- USA Stock  

USD 126.06  1.79  1.44%

  Chairman
Mr. Michael B. McCallister is NonExecutive Independent Chairman of the Board of Zoetis Inc. Mr. McCallister joined Humana in 1974, and was its Chief Executive Officer from February 2000 until his retirement in December 2012. During his tenure as CEO, Humana gained a reputation as one of the industrys leading peoplefocused innovative companies, leveraging products, processes and technology to help individuals take control of their own health. He also served as Chairman of the Board of Humana from 2010 to 2013. Mr. McCallister served for many years on the board of the Business Roundtable and was Chairman of its Health and Retirement Task Force. He currently serves on the boards of ATT and Fifth Third Bank. Mr. McCallister holds a bachelors degree in accounting from Louisiana Tech University and an MBA from Pepperdine University. Mr. McCallisters senior management experience in the health care industry, along with his public company board experience, make him a valuable member of our Board.
Age: 65  Chairman Since 2015  MBA    
973-822-7000  http://www.zoetis.com
McCallister holds a bachelor?s degree in accounting from Louisiana Tech University and an MBA from Pepperdine University.

Michael McCallister Latest Insider Activity

Management Efficiency

The company has Return on Asset of 12.56 % which means that on every $100 spent on asset it made $12.56 of profit. This is considered to be average in the sector. In the same way, it shows return on shareholders equity (ROE) of 62.6 % implying that it generated $62.6 on every 100 dollars invested.
The company has 6.65B in debt with debt to equity (D/E) ratio of 275.9 . This implies that the company may be unable to create cash to meet all of its financial commitments. Zoetis has Current Ratio of 4.09 demonstrating that it is liquid and is capable to disburse its financial commitments when the payables are due.

Similar Executives

Found 9 records

CHAIRMAN Since

Roy VagelosRegeneron Pharmaceuticals
1995
Joseph PapaPerrigo Company plc
2015
Marry BrlasPerrigo Company plc
2016
Satish ReddyDr Reddys Laboratories Ltd
2014
Gengchen HanOrigin Agritech Limited
2016
Joshua BogerVertex Pharmaceuticals Incorpor
2009
Jeffrey LeidenVertex Pharmaceuticals Incorpor
2012
G PrasadDr Reddys Laboratories Ltd
2014
Yasheng YangOrigin Agritech Limited
2010

Entity Summary

Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. The company was founded in 1952 and is headquartered in Parsippany, New Jersey. Zoetis operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 10000 people.Zoetis (ZTS) is traded on BATS Exchange in USA and employs 10,000 people.

Zoetis Leadership Team

Roman Trawicki, Executive Vice President and Presidentident of Global Manufacturing and Supply
Kristin Peck, Executive Vice President and Group President, U.S. Operations, Business Development and Strategy
William Steere, Independent Director
Roxanne Lagano, Executive Vice President, Chief Human Resources Officer and Communications
Linda Rhodes, Independent Director
Frank DAmelio, Independent Director
Robert Scully, Independent Director
Clinton Lewis, Executive Vice President and Group President, International Operations, Commercial Development, Global Genetics, Aquatic Health and Human Medical Diagnostics
Stefan Weiskopf, Executive Vice President and Area President of the Asia Pacific, Australia and New Zealand
Sanjay Khosla, Independent Director
Paul Herendeen, CFO and Executive VP
Catherine Knupp, Executive Vice President, President - Research and Development
Michael McCallister, Non-Executive Independent Chairman of the Board
Paul Bisaro, Independent Director
Alejandro Bernal, Executive Vice President and Area President of the Europe, Africa and Middle East region
Willie Reed, Independent Director
Joyce Lee, Executive Vice President and Area President of the Canada and Latin America region
Glenn David, Chief Financial Officer, Executive Vice President
Sandra Beaty, Executive Vice President - Corporate Affairs
William Doyle, Director
Andrew Fenton, Executive Vice President and Chief Digital and Technology Officer
Gregory Norden, Independent Director
Louise Parent, Independent Director
Heidi Chen, Executive Vice President General Counsel, Corporate Secretary
Juan Alaix, Chief Executive Officer, Director

Stock Performance Indicators

Current Sentiment - ZTS

Zoetis Investor Sentiment

Greater number of Macroaxis users are at this time bullish on Zoetis. What is your take regarding investing in Zoetis? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Also Currentnly Active

Purchased few shares of
a day ago
Traded for 188.14
Purchased a lot of shares of
a day ago
Traded for 150.35
Purchased few shares of
a day ago
Traded for 175.29
See also Your Current Watchlist. Please also try Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Search macroaxis.com